On December 8, 2022, Shuangcheng Pharmaceuticals Europe S.r.l closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.32 CNY | 0.00% |
|
-3.36% | -42.48% |
May. 22 | Workshop of Shuangcheng Pharma's Unit Passes Regulatory Inspection; Shares Up 3% | MT |
May. 07 | Shuangcheng Pharma Gets FDA Nod to Market Acromegaly Drug in US | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.48% | 248M | |
+25.88% | 44.74B | |
+33.30% | 23.36B | |
+25.31% | 16.24B | |
+21.32% | 14.39B | |
+69.10% | 13.96B | |
-13.89% | 6.4B | |
-8.87% | 5.73B | |
+15.70% | 5.68B | |
+12.06% | 4.92B |
- Stock Market
- Equities
- 002693 Stock
- News Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- Shuangcheng Pharmaceuticals Europe S.r.l announced that it has received €0.05 million in funding from Hainan Shuangcheng Pharmaceuticals Co., Ltd.